Friday, August 8, 2008

Clinical Trials: Renal Cell Carcinoma

Renal Cell Carcinoma

If you are 18 or older, have histologically or cytologically confirmed renal cell carcinoma, and have failed or are intolerant to one or more previous lines of treatment (which must include a tyrosine kinase inhibitor), you may qualify for this study.

The research site is in Beech Grove, Ind.

More information

Please see http://www.centerwatch.com/patient/studies/cat363.html.